Ironwood Pharmaceuticals, Inc. (IRWD) Stock: What Does the Chart Say Friday?

Ironwood Pharmaceuticals, Inc. (IRWD) stock has fallen 1.10% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Ironwood Pharmaceuticals, Inc. has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on IRWD!

See Full IRWD Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With IRWD Stock Today?

Ironwood Pharmaceuticals, Inc. (IRWD) stock is up 0.45% while the S&P 500 is down -0.42% as of 12:55 PM on Friday, Mar 8. IRWD has risen $0.04 from the previous closing price of $8.93 on volume of 2,563,042 shares. Over the past year the S&P 500 has risen 28.65% while IRWD is down -16.48%. IRWD lost -$6.45 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Ironwood Pharmaceuticals, Inc. click here.

More About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. Click Here to get the full Stock Report for Ironwood Pharmaceuticals, Inc. stock.